logo
  

GSK Signs Addl Purchase Agreements With Canada For COVID-19 Monoclonal Antibody Therapy, Sotrovimab

GlaxoSmithKline Plc. (GSK.L,GSK) said that it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab for injection. Sotrovimab is a COVID-19 monoclonal antibody therapy developed by GSK and Vir Biotechnology.

It follows the initial purchase agreement with the Government of Canada to supply 10,000 doses of Sotrovimab, announced on October 4, 2021.

Health Canada authorized Sotrovimab for injection on July 30, 2021, under its Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 for the treatment of mild to moderate COVID-19, confirmed by direct SARS-COV-2 viral testing, in adults and adolescents (12 years of age and older weighing at least 40 kg) who are at high risk for progressing to hospitalization and/or death.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Asweets Global Inc. is recalling about 2,000 units of Wonder & Wise Activity Tables for potential risk of choking hazard to young children, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the screws of the tables can become loose and/or detach from the xylophone component of the activity tables to pose a choking hazard to young children. Chinese e-commerce giant Alibaba Group Holdings Ltd. (BABA) reported Thursday a net loss for the fourth quarter that sharply widened from last year, despite 9 percent growth in revenues, hurt by a decreases in the market prices of our equity investments in publicly-traded companies. Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared...
Follow RTT